Pixuvri
Cases of skin cancer set to reach 263,000 in 2035 according to new report
The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe
Accession announces major UK market access consulting milestone
February 5th 2025: Today Accession Healthcare Consulting Ltd (Accession) has announced the achievement of a major consulting milestone as it enters its 15th year as a specialist provider of UK...
Janssen signs $245m deal with Cellular Biomedicine for pair of CAR T-cell therapies
The candidates have shown the potential to treat forms of non-Hodgkin’s lymphoma
Kate Shaw comments the appointment of an independent review on clinical trials in the UK.
The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five...
BeiGene’s Brukinsa receives EC approval for marginal zone lymphoma
The BTK inhibitor was also granted an additional year of marketing protection
AbbVie submits application for lymphoma therapy epcoritamab to EMA
Phase 2 trial showed an overall response rate of 63% and a complete response rate of 39%
J&J’s single-dose COVID-19 vaccine secures approval from the UK’s MHRA
Vaccine was found to be 67% effective in preventing COVID-19 infection in a phase 3 study
EU, UK working towards a ‘win-win’ situation to expand COVID-19 vaccine supplies
EU leaders are set to meet today to discuss proposed vaccine export plans
EU-UK COVID-19 vaccine row continues as export ban discussion looms
EU officials are set to discuss imposing a vaccine export ban this week
UK hits ‘significant milestone’ as 15 million people receive their first COVID-19 vaccine dose
The NHS also announced that five additional large-scale vaccination centres will open this week
New dosing option for AZ’s Imfinzi approved in the EU and UK
Additional option extends dosing from two weeks to four weeks
